πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 812 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7887812

Live attenuated Leishmania vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7888069

Plant-made west nile virus (WNV) vaccines, vectors and plant codon optimized sequences

The United States of America as represented by the Secretary of Argriculture Β· Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7887818

Neospora caninum vaccine

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7883710

Peptide vaccines against Group A streptococci

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7862821

Recombinant vaccine against bluetongue virus

The Regents of the University of California Β· Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7851194

West Nile viruses with mutations in the 3β€² terminal stem and loop secondary structure for

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7846450

Melanoma associated peptide analogues and vaccines against melanoma

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7846675

Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7842798

Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7829102

Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7824690

Marek's disease virus vaccine

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7820395

Orientia tsutsugamushi truncated recombinant outer membrane protein (R47) and (R56) vaccin

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7807168

Selection of human TNFΞ± specific antibodies

VACCINEX, INC. Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7794726

Mutants of lysine decarboxylase, vaccines for periodontitis, and methods of use

The Boards of Regents of the University of Oklahoma Β· Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7794734

Mannheimia haemolytica chimeric outer membrane protein PlpE and leukotoxin epitopes as a v

The Board of Regents for Oklahoma State University Β· Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7794730

Polyvalent attenuated live vaccine for preventing and curing vibriosis of cultivated fish

East China University of Science and Technology Β· Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790186

Plasmodium vivax hybrid circumsporozoite protein and vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790181

Live attenuated viral vaccines for Eastern Equine Encephalitis virus

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790182

Protein vaccines against poxviruses

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7786285

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776537

Method of preparing a PRRS virus vaccine

Regents of the University of Minnesota Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7767210

RNA virus vaccines and methods

The Board of Regents of the University of Oklahoma Β· Granted Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7763451

Methods for preparing Bacillus anthracis protective antigen for use in vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7763259

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus in

The Regents of the University of Colorado Β· Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted